• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自然杀伤细胞限制衰老肺腺癌细胞的清除。

Natural killer cells limit the clearance of senescent lung adenocarcinoma cells.

作者信息

Stokes Kate L, Cortez-Retamozo Virna, Acosta Jonuelle, Lauderback Brian, Robles-Oteiza Camila, Cicchini Michelle, Pittet Mikael J, Feldser David M

机构信息

Department of Cancer Biology, University of Pennsylvania, 421 Curie Blvd., 751 BRB II/III, Philadelphia, PA, 19104-6160, USA.

Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, MA, 02114, USA.

出版信息

Oncogenesis. 2019 Apr 1;8(4):24. doi: 10.1038/s41389-019-0133-3.

DOI:10.1038/s41389-019-0133-3
PMID:30936429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6443683/
Abstract

Senescence is an important p53-controlled tumor suppressor program that not only opposes the proliferation of cancer cells but also promotes their immune-mediated clearance in certain contexts. In hepatocellular cancer, p53 induction promotes an innate immune cell-mediated clearance of senescent cells wherein natural killer (NK) cells seem to play the primary sentinel role. Whether NK cells also surveil cancer cells in other tumor types when p53 is activated to promote a senescence response is unknown. To identify the role that NK and other innate immune cell types have on the surveillance and destruction of lung adenocarcinoma cells, we developed an orthotopic transplantation model where p53 gene function could be restored to induce senescence after successful engraftment of tumor cells in the mouse lung. Contrary to precedent, we found that NK cells actually limited the efficient clearance of tumor cells from the mouse lung after p53 restoration. Instead, activation of p53 induced the infiltration of monocytes, neutrophils, and interstitial macrophages. Loss of NK cells further promoted expansion of these inflammatory cell types and tumor clearance after p53 restoration. These observations suggest that NK cell responses to p53 activation in lung adenocarcinoma is distinct from those found in other tumor types and that diverse innate immune cell populations may play context-dependent roles during tumor immune surveillance. Further, our data provide an impetus to understand the broader mechanisms that regulate cancer cell destruction by multiple cell types of the innate immune system and distinct cancer contexts.

摘要

衰老 是一种重要的由p53调控的肿瘤抑制程序,它不仅能抑制癌细胞的增殖,还能在某些情况下促进癌细胞的免疫介导清除。在肝细胞癌中,p53的诱导促进了衰老细胞的先天性免疫细胞介导清除,其中自然杀伤(NK)细胞似乎发挥着主要的哨兵作用。当p53被激活以促进衰老反应时,NK细胞是否也会监测其他肿瘤类型中的癌细胞尚不清楚。为了确定NK细胞和其他先天性免疫细胞类型在肺腺癌细胞监测和破坏中的作用,我们建立了一种原位移植模型,在该模型中,在肿瘤细胞成功植入小鼠肺部后,可以恢复p53基因功能以诱导衰老。与之前的研究相反,我们发现p53恢复后,NK细胞实际上限制了肿瘤细胞从小鼠肺部的有效清除。相反,p53的激活诱导了单核细胞、中性粒细胞和间质巨噬细胞的浸润。NK细胞的缺失进一步促进了这些炎症细胞类型的扩增以及p53恢复后的肿瘤清除。这些观察结果表明,肺腺癌中NK细胞对p53激活的反应与其他肿瘤类型不同,并且不同的先天性免疫细胞群体在肿瘤免疫监测过程中可能发挥依赖于背景的作用。此外,我们的数据为理解调节先天性免疫系统多种细胞类型和不同癌症背景下癌细胞破坏的更广泛机制提供了动力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe63/6443683/9ee92adc271f/41389_2019_133_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe63/6443683/e3f0a7c2635e/41389_2019_133_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe63/6443683/2eb9996dab76/41389_2019_133_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe63/6443683/3ad5e34a6020/41389_2019_133_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe63/6443683/ea7801bf1ea1/41389_2019_133_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe63/6443683/cd756430647d/41389_2019_133_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe63/6443683/95be319cb433/41389_2019_133_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe63/6443683/9ee92adc271f/41389_2019_133_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe63/6443683/e3f0a7c2635e/41389_2019_133_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe63/6443683/2eb9996dab76/41389_2019_133_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe63/6443683/3ad5e34a6020/41389_2019_133_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe63/6443683/ea7801bf1ea1/41389_2019_133_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe63/6443683/cd756430647d/41389_2019_133_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe63/6443683/95be319cb433/41389_2019_133_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe63/6443683/9ee92adc271f/41389_2019_133_Fig7_HTML.jpg

相似文献

1
Natural killer cells limit the clearance of senescent lung adenocarcinoma cells.自然杀伤细胞限制衰老肺腺癌细胞的清除。
Oncogenesis. 2019 Apr 1;8(4):24. doi: 10.1038/s41389-019-0133-3.
2
Senescent cells: Living or dying is a matter of NK cells.衰老细胞:生死存亡取决于 NK 细胞。
J Leukoc Biol. 2019 Jun;105(6):1275-1283. doi: 10.1002/JLB.MR0718-299R. Epub 2019 Feb 27.
3
Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.人类自然杀伤细胞通过上调 NKG2D 配体 ULBP1 和 ULBP2 而对癌细胞中 p53 的诱导作出反应。
Cancer Res. 2011 Sep 15;71(18):5998-6009. doi: 10.1158/0008-5472.CAN-10-3211. Epub 2011 Jul 15.
4
Restoration of p53 function: a new therapeutic strategy to induce tumor regression?恢复p53功能:诱导肿瘤消退的一种新治疗策略?
Hepatology. 2007 Jun;45(6):1578-9. doi: 10.1002/hep.21789.
5
Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2.通过诱导 ULBP2,p53 的药理学激活触发了抗癌先天免疫反应。
Cell Cycle. 2011 Oct 1;10(19):3346-58. doi: 10.4161/cc.10.19.17630.
6
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.衰老和肿瘤清除是由小鼠肝癌中p53的恢复触发的。
Nature. 2007 Feb 8;445(7128):656-60. doi: 10.1038/nature05529. Epub 2007 Jan 24.
7
Autologous Immune Enhancement Therapy for Cancer - Our experience since 2004.癌症自体免疫增强疗法——我们自2004年以来的经验
J Stem Cells Regen Med. 2012 Nov 26;8(3):205-6. eCollection 2012.
8
The role of natural killer cells in adenovirus-mediated p53 gene therapy.自然杀伤细胞在腺病毒介导的p53基因治疗中的作用。
Mol Cancer Ther. 2001 Nov;1(1):49-60.
9
Aneuploid senescent cells activate NF-κB to promote their immune clearance by NK cells.非整倍体衰老细胞激活 NF-κB 促进 NK 细胞对其免疫清除。
EMBO Rep. 2021 Aug 4;22(8):e52032. doi: 10.15252/embr.202052032. Epub 2021 Jun 8.
10
Activated Tissue-Resident Mesenchymal Stromal Cells Regulate Natural Killer Cell Immune and Tissue-Regenerative Function.活化的组织驻留间充质基质细胞调节自然杀伤细胞免疫和组织再生功能。
Stem Cell Reports. 2017 Sep 12;9(3):985-998. doi: 10.1016/j.stemcr.2017.06.020. Epub 2017 Aug 3.

引用本文的文献

1
PP2C phosphatases-terminators of suicidal thoughts.PP2C磷酸酶——自杀念头的终结者。
Cell Death Dis. 2024 Dec 19;15(12):919. doi: 10.1038/s41419-024-07269-2.
2
S-acylation of Ca transport proteins in cancer.癌症中钙转运蛋白的S-酰化作用
Chronic Dis Transl Med. 2024 Aug 14;10(4):263-280. doi: 10.1002/cdt3.146. eCollection 2024 Dec.
3
Master regulator: p53's pivotal role in steering NK-cell tumor patrol.主调控因子:p53 在引导 NK 细胞肿瘤巡弋中的关键作用。

本文引用的文献

1
NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination.自然杀伤细胞介导的细胞毒性有助于细胞抑制剂药物组合控制肿瘤。
Science. 2018 Dec 21;362(6421):1416-1422. doi: 10.1126/science.aas9090.
2
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.致癌性RAS信号通过稳定PD-L1 mRNA促进肿瘤免疫抗性。
Immunity. 2017 Dec 19;47(6):1083-1099.e6. doi: 10.1016/j.immuni.2017.11.016. Epub 2017 Dec 12.
3
Myc Cooperates with Ras by Programming Inflammation and Immune Suppression.
Front Immunol. 2024 Aug 9;15:1428653. doi: 10.3389/fimmu.2024.1428653. eCollection 2024.
4
p53 at the crossroads of tumor immunity.p53 在肿瘤免疫的十字路口。
Nat Cancer. 2024 Jul;5(7):983-995. doi: 10.1038/s43018-024-00796-z. Epub 2024 Jul 15.
5
A Six-gene Prognostic Model Based on Neutrophil Extracellular Traps (NETs)-related Gene Signature for Lung Adenocarcinoma.基于中性粒细胞胞外诱捕网(NETs)相关基因特征的肺腺癌 6 基因预后模型。
Comb Chem High Throughput Screen. 2024;27(13):1969-1983. doi: 10.2174/0113862073282003240119064337.
6
p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanism.p53 修复可识别小细胞肺癌中潜在的亲环素依赖性坏死机制。
Nat Commun. 2023 Jul 21;14(1):4403. doi: 10.1038/s41467-023-40161-9.
7
Could senescence phenotypes strike the balance to promote tumor dormancy?衰老表型能否打破平衡促进肿瘤休眠?
Cancer Metastasis Rev. 2023 Mar;42(1):143-160. doi: 10.1007/s10555-023-10089-z. Epub 2023 Feb 3.
8
Cellular senescence and senolytics: the path to the clinic.细胞衰老与衰老细胞清除:通往临床的道路。
Nat Med. 2022 Aug;28(8):1556-1568. doi: 10.1038/s41591-022-01923-y. Epub 2022 Aug 11.
9
Pharmacological CDK4/6 inhibition reveals a p53-dependent senescent state with restricted toxicity.药理 CDK4/6 抑制揭示了一种依赖 p53 的衰老状态,其毒性受限。
EMBO J. 2022 Mar 15;41(6):e108946. doi: 10.15252/embj.2021108946. Epub 2022 Jan 5.
10
Tissues and Tumor Microenvironment (TME) in 3D: Models to Shed Light on Immunosuppression in Cancer.三维组织和肿瘤微环境(TME):揭示癌症免疫抑制的模型。
Cells. 2021 Apr 7;10(4):831. doi: 10.3390/cells10040831.
Myc通过调控炎症和免疫抑制与Ras协同作用。
Cell. 2017 Nov 30;171(6):1301-1315.e14. doi: 10.1016/j.cell.2017.11.013.
4
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer.表观遗传疗法将MYC缺失与逆转免疫逃逸及治疗肺癌联系起来。
Cell. 2017 Nov 30;171(6):1284-1300.e21. doi: 10.1016/j.cell.2017.10.022.
5
Roles for Innate Immunity in Combination Immunotherapies.固有免疫在联合免疫疗法中的作用。
Cancer Res. 2017 Oct 1;77(19):5215-5221. doi: 10.1158/0008-5472.CAN-17-1340. Epub 2017 Sep 19.
6
Putting p53 in Context.将p53置于背景中考虑。
Cell. 2017 Sep 7;170(6):1062-1078. doi: 10.1016/j.cell.2017.08.028.
7
Emerging roles of p53 and other tumour-suppressor genes in immune regulation.p53及其他肿瘤抑制基因在免疫调节中的新作用。
Nat Rev Immunol. 2016 Dec;16(12):741-750. doi: 10.1038/nri.2016.99. Epub 2016 Sep 26.
8
Cellular senescence: from physiology to pathology.细胞衰老:从生理学到病理学。
Nat Rev Mol Cell Biol. 2014 Jul;15(7):482-96. doi: 10.1038/nrm3823.
9
New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape.癌症免疫编辑及其三个组成阶段——消除、平衡和逃逸的新见解。
Curr Opin Immunol. 2014 Apr;27:16-25. doi: 10.1016/j.coi.2014.01.004. Epub 2014 Feb 14.
10
Revisiting the Prominent Anti-Tumoral Potential of Pre-mNK Cells.重新审视前体自然杀伤细胞显著的抗肿瘤潜力。
Front Immunol. 2013 Dec 11;4:446. doi: 10.3389/fimmu.2013.00446.